| Literature DB >> 14630813 |
Yoko Tabe1, Marina Konopleva, Mark F Munsell, Frank C Marini, Claudia Zompetta, Teresa McQueen, Twee Tsao, Shourong Zhao, Sherry Pierce, Jun Igari, Elihu H Estey, Michael Andreeff.
Abstract
Leptin is secreted by bone marrow (BM) adipocytes and stromal cells and was shown to stimulate myeloid proliferation. We here report that primary acute promyelocytic leukemia (APL) cells express high levels of the leptin-receptor (OB-R) long isoform. In cells with regulated promyelocytic leukemia-retinoic acid receptor (PML-RARalpha) expression, inducing PML-RARalpha was found to increase OB-R levels. We then investigated the effects of leptin produced by BM adipocytes on APL cells using a coculture system with mesenchymal stem cell (MSC)-derived adipocytes. In PML-RARalpha-expressing cells, all-trans retinoic acid (ATRA)- and doxorubicin-induced apoptosis were significantly reduced by coculture with adipocyte-differentiated MSCs. This antiapoptotic effect required direct cell-to-cell interactions, was associated with phosphorylation of signal transducer and activator of transcription-3 (STAT3) and mitogen-activated protein kinase (MAPK), and was reduced by blocking OB-R. This report provides a mechanistic basis for the BM adipocyte-leukemia cell interaction and suggests that OB-R receptor blockade may have therapeutic use in APL.Entities:
Mesh:
Substances:
Year: 2003 PMID: 14630813 DOI: 10.1182/blood-2003-03-0802
Source DB: PubMed Journal: Blood ISSN: 0006-4971 Impact factor: 22.113